Bio-Rad Labs (BIO) Misses Q4 EPS by 16c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/31/2026
- Wall Street closes sharply lower as AI cash burn fears spark tech selloff
- Amazon burns cash, Intel flags weak PC demand as AI boom's costs ripple across markets
- Bitcoin, cryptocurrency prices fall after Binance reports security issue
- Higher yields now hurting AI stock bull as bond markets police capex: BofA
- Oil jumps 2%, settles at 6-month highs on fears of escalation in Iran
Tweet
Share
E-mail
Get Alerts BIO Hot Sheet
Price: $372.18 -3.18%
Revenue Growth %: -0.5%
Financial Fact:
Selling, general and administrative expense: 205.54M
Today's EPS Names:
OPY, BNCC, ZVOI, More
Revenue Growth %: -0.5%
Financial Fact:
Selling, general and administrative expense: 205.54M
Today's EPS Names:
OPY, BNCC, ZVOI, More
Join SI Premium – FREE
Bio-Rad Labs (NYSE: BIO) reported Q4 EPS of $3.31, $0.16 worse than the analyst estimate of $3.47. Revenue for the quarter came in at $730.3 million versus the consensus estimate of $747.26 million.
For earnings history and earnings-related data on Bio-Rad Labs (BIO) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Evercose ISI downgrades Reddit, says monetization may not offset traffic weakness
- John B. Sanfilippo & Son, Inc. (JBSS) PT Lowered to $79 at Freedom Broker
- Goldman Sachs Revises China Jewelry Stocks Amid Gold Price Retreat
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
